Latest updates for Schering Ag

Fresh curated links around Schering AG are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • <![CDATA[Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpha
  • Merck KGaA pledges $50M to build new cardio biotech with eye to later acquisition
  • End-to-end: Curia drives supply and scale for steroid and hormonal therapies

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

pharmexec.com /6 days ago

&lt;![CDATA[Pharma M&amp;A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpha...

Read source
fiercebiotech.com /3 weeks ago

Merck KGaA pledges $50M to build new cardio biotech with eye to later acquisition

Merck KGaA has committed $50 million to build a new biotech with prolific life science investor Versant Ventures, with the ultimate goal of devouring the NewCo down the line.

Read source
labiotech.eu /2 days ago

End-to-end: Curia drives supply and scale for steroid and hormonal therapies

Explore how Curia tackles steroid manufacturing complexity, from early development to scaled, end-to-end commercial supply. The post End-to-end: Curia drives supply and scale for s...

Read source
fiercebiotech.com /2 weeks ago

Chutes &amp; Ladders—EMD Serono taps in new commercial strategy head

EMD Serono, Merck KGaA’s North American healthcare arm, has promoted from within to replace its retiring head of global commercial strategy, Andrew Paterson. Taking the commercial...

Read source
pharmexec.com /2 weeks ago

&lt;![CDATA[Pharmaceutical Executive Daily: Ipsen Enters Merger Agreement to Acquire Kartos Therapeutics]]&gt;

Read source
pharmexec.com /1 week ago

&lt;![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Pharma M&amp;A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters L...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Start creating posts

Sources covering Schering Ag

fiercebiotech.com

Recent coverage from public sources
Public source

labiotech.eu

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source

Related searches

us CDMO Clinical trial Drug development Sponsored

Recent searches

Artificial Intelligence Machine Learning Data Science Data Engineering Business Intelligence Web Development Software Development Software Testing Programming JavaScript DevOps Cyber Security Product Management Project Management Design UX UX Research Graphic Design Video Production Video Editing